Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 4.59M | $ 2.33M | $ 4.73M | $ 1.94M | $ 1.63M |
Total Assets | $ 41.27M | $ 41.50M | $ 43.03M | $ 42.96M | $ 40.15M |
Total Debt | $ ― | $ ― | $ ― | $ ― | $ ― |
Net Debt | $ ― | $ ― | $ ― | $ ― | $ ― |
Total Liabilities | $ 5.36M | $ 5.36M | $ 5.53M | $ 7.39M | $ 6.10M |
Stockholders Equity | $ 36.94M | $ 36.43M | $ 37.78M | $ 35.46M | $ 33.95M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |